Call us on+91-7490041245
Get a Quote
EnglishSpanishPortugueseFrench
Carbamazepine Tablets 400 mg
Carbamazepine Tablets 400 mg
Carbamazepine Tablets 400 mg
Inquiry Submitted Successfully

Carbamazepine Tablets 400 mg

  • Product Name : Carbamazepine Tablets 400 mg
  • Trade Name: Tegrawell-400
  • Available Strength : 200mg,400mg
  • Packing : 10X10 Tablets
  • Pack Insert/Leaflet : Yes
  • Therapeutic use : Antiepileptic,Anticonvulsant
  • Production Capacity : 1 million tablet/month

Description

Carbamazepine Tablets 400 mg- Manufacturer and Exporter

Carbamazepine Tablets 400 mg contain Carbamazepine, a widely prescribed anticonvulsant and mood-stabilizing medication used to treat neurological and psychiatric conditions. These tablets are commonly recommended for managing epilepsy, seizures, trigeminal neuralgia, and bipolar disorder.

Manufactured under strict quality standards, Carbamazepine 400 mg tablets offered by Wellona Pharma are known for their effectiveness, safety, and global compliance. As a trusted pharmaceutical manufacturer and exporter, Wellona Pharma supplies high-quality Carbamazepine tablets to international markets, ensuring consistent therapeutic performance.

Uses of Carbamazepine Tablets 400 mg

  • Treatment of epileptic seizures (partial and generalized seizures)
  • Management of trigeminal neuralgia (severe facial nerve pain)
  • Control of bipolar disorder (mood stabilization)
  • Occasionally used for certain types of nerve pain

Benefits

  • Helps control abnormal electrical activity in the brain
  • Reduces frequency and severity of seizures
  • Provides relief from nerve-related pain
  • Stabilizes mood swings in psychiatric conditions

Side Effects of Carbamazepine Tablets

  • Dizziness or drowsiness
  • Nausea and vomiting
  • Unsteadiness or coordination problems
  • Blurred or double vision

Why Choose Wellona Pharma?

  • Leading Carbamazepine Tablets manufacturer and exporter
  • High-quality formulations meeting international standards
  • Reliable bulk supply for global pharmaceutical markets